🇺🇸 FDA
Pipeline program

Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete

KCT10/2022-LEASH

Approved small_molecule active

Quick answer

Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete for Hyperlipidaemia is a Approved program (small_molecule) at Novo mesto with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo mesto
Indication
Hyperlipidaemia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials